Lutetium-177 PSMA-I&T
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lutetium-177 PSMA-I&T, covering 2025-02-07 to 2025-02-07. Get the full timeline:
Most recent: Clinical Trial Update: Combination of Radium-223 and Lutetium-177 PSMA-I&T in Men with Metastatic Castration-Resistant Prostate Cancer [Phase 1, Phase 2]